uncommon bio limited
uncommon bio limited Company Information
Company Number
11243383
Website
highersteaks.comRegistered Address
unit 2 cambridge technopark, newmarket road, cambridge, cambridgeshire, CB5 8PB
Industry
Production of meat and poultry meat products
Research and experimental development on biotechnology
Telephone
-
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
benjamina aure bollag 33.7%
apollo projects lp 17.2%
View Alluncommon bio limited Estimated Valuation
Pomanda estimates the enterprise value of UNCOMMON BIO LIMITED at £5m based on a Turnover of £5.4m and 0.92x industry multiple (adjusted for size and gross margin).
uncommon bio limited Estimated Valuation
Pomanda estimates the enterprise value of UNCOMMON BIO LIMITED at £0 based on an EBITDA of £-3.4m and a 5.1x industry multiple (adjusted for size and gross margin).
uncommon bio limited Estimated Valuation
Pomanda estimates the enterprise value of UNCOMMON BIO LIMITED at £0 based on Net Assets of £-4.7m and 2.11x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Uncommon Bio Limited Overview
Uncommon Bio Limited is a live company located in cambridge, CB5 8PB with a Companies House number of 11243383. It operates in the production of meat and poultry meat products sector, SIC Code 10130. Founded in March 2018, it's largest shareholder is benjamina aure bollag with a 33.7% stake. Uncommon Bio Limited is a young, mid sized company, Pomanda has estimated its turnover at £5.4m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Uncommon Bio Limited Health Check
Pomanda's financial health check has awarded Uncommon Bio Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £5.4m, make it smaller than the average company (£15.2m)
- Uncommon Bio Limited
£15.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 128%, show it is growing at a faster rate (9%)
- Uncommon Bio Limited
9% - Industry AVG
Production
with a gross margin of 36%, this company has a comparable cost of product (36%)
- Uncommon Bio Limited
36% - Industry AVG
Profitability
an operating margin of -78.7% make it less profitable than the average company (1.6%)
- Uncommon Bio Limited
1.6% - Industry AVG
Employees
with 41 employees, this is below the industry average (74)
41 - Uncommon Bio Limited
74 - Industry AVG
Pay Structure
on an average salary of £51.2k, the company has an equivalent pay structure (£51.2k)
- Uncommon Bio Limited
£51.2k - Industry AVG
Efficiency
resulting in sales per employee of £132.9k, this is less efficient (£177.2k)
- Uncommon Bio Limited
£177.2k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Uncommon Bio Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 99 days, this is slower than average (48 days)
- Uncommon Bio Limited
48 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Uncommon Bio Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 9 weeks, this is less cash available to meet short term requirements (23 weeks)
9 weeks - Uncommon Bio Limited
23 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 139.9%, this is a higher level of debt than the average (52.3%)
139.9% - Uncommon Bio Limited
52.3% - Industry AVG
UNCOMMON BIO LIMITED financials
Uncommon Bio Limited's latest turnover from March 2023 is estimated at £5.4 million and the company has net assets of -£4.7 million. According to their latest financial statements, Uncommon Bio Limited has 41 employees and maintains cash reserves of £3.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|
| Turnover | |||||
| Other Income Or Grants | |||||
| Cost Of Sales | |||||
| Gross Profit | |||||
| Admin Expenses | |||||
| Operating Profit | |||||
| Interest Payable | |||||
| Interest Receivable | |||||
| Pre-Tax Profit | |||||
| Tax | |||||
| Profit After Tax | |||||
| Dividends Paid | |||||
| Retained Profit | |||||
| Employee Costs | |||||
| Number Of Employees | 41 | 19 | 4 | 3 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|
| Tangible Assets | 6,036,277 | 697,748 | 76,129 | 0 | 0 |
| Intangible Assets | 161,620 | 29,389 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 6,197,897 | 727,137 | 76,129 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 2,348,604 | 886,361 | 161,878 | 3,797 | 3,992 |
| Cash | 3,139,421 | 15,110,602 | 3,060,264 | 13,614 | 114,045 |
| misc current assets | 0 | 0 | 0 | 0 | 0 |
| total current assets | 5,488,025 | 15,996,963 | 3,222,142 | 17,411 | 118,037 |
| total assets | 11,685,922 | 16,724,100 | 3,298,271 | 17,411 | 118,037 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 951,353 | 232,575 | 34,783 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 15,000,000 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 397,481 | 96,425 | 2,166,537 | 12,107 | 165,771 |
| total current liabilities | 16,348,834 | 329,000 | 2,201,320 | 12,107 | 165,771 |
| loans | 0 | 15,000,000 | 0 | 0 | 607 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 199,242 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 15,000,000 | 0 | 199,242 | 607 |
| total liabilities | 16,348,834 | 15,329,000 | 2,201,320 | 211,349 | 166,378 |
| net assets | -4,662,912 | 1,395,100 | 1,096,951 | -193,938 | -48,341 |
| total shareholders funds | -4,662,912 | 1,395,100 | 1,096,951 | -193,938 | -48,341 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | |||||
| Depreciation | 906,810 | 72,484 | 3,071 | 0 | 0 |
| Amortisation | 14,735 | 1,400 | 0 | 0 | 0 |
| Tax | |||||
| Stock | 0 | 0 | 0 | 0 | 0 |
| Debtors | 1,462,243 | 724,483 | 158,081 | -195 | 3,992 |
| Creditors | 718,778 | 197,792 | 34,783 | 0 | 0 |
| Accruals and Deferred Income | 301,056 | -2,070,112 | 2,154,430 | -153,664 | 165,771 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||
| Investing Activities | |||||
| capital expenditure | |||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||
| Financing Activities | |||||
| Bank loans | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 15,000,000 | 0 | 0 | 0 | 0 |
| Long term loans | -15,000,000 | 15,000,000 | 0 | -607 | 607 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | -199,242 | 199,242 | 0 |
| share issue | |||||
| interest | |||||
| cash flow from financing | |||||
| cash and cash equivalents | |||||
| cash | -11,971,181 | 12,050,338 | 3,046,650 | -100,431 | 114,045 |
| overdraft | 0 | 0 | 0 | 0 | 0 |
| change in cash | -11,971,181 | 12,050,338 | 3,046,650 | -100,431 | 114,045 |
uncommon bio limited Credit Report and Business Information
Uncommon Bio Limited Competitor Analysis
Perform a competitor analysis for uncommon bio limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in CB5 area or any other competitors across 12 key performance metrics.
uncommon bio limited Ownership
UNCOMMON BIO LIMITED group structure
Uncommon Bio Limited has no subsidiary companies.
Ultimate parent company
UNCOMMON BIO LIMITED
11243383
uncommon bio limited directors
Uncommon Bio Limited currently has 4 directors. The longest serving directors include Ms Benjamina Bollag (Mar 2018) and Mr Daniel Waterhouse (Mar 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Benjamina Bollag | England | 31 years | Mar 2018 | - | Director |
| Mr Daniel Waterhouse | England | 53 years | Mar 2022 | - | Director |
| Mr Daniel Waterhouse | England | 53 years | Mar 2022 | - | Director |
| Ms Clea Kolster | England | 32 years | Mar 2022 | - | Director |
P&L
March 2023turnover
5.4m
+166%
operating profit
-4.3m
0%
gross margin
36%
+8.53%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
-4.7m
-4.34%
total assets
11.7m
-0.3%
cash
3.1m
-0.79%
net assets
Total assets minus all liabilities
uncommon bio limited company details
company number
11243383
Type
Private limited with Share Capital
industry
10130 - Production of meat and poultry meat products
72110 - Research and experimental development on biotechnology
incorporation date
March 2018
age
6
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2023
previous names
highersteaks limited (June 2023)
accountant
MAX ACCOUNTANTS LTD
auditor
-
address
unit 2 cambridge technopark, newmarket road, cambridge, cambridgeshire, CB5 8PB
Bank
-
Legal Advisor
-
uncommon bio limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to uncommon bio limited.
uncommon bio limited Companies House Filings - See Documents
| date | description | view/download |
|---|
